Bailly J E, McAuliffe J M, Skiadopoulos M H, Collins P L, Murphy B R
National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892 USA.
Virus Genes. 2000;20(2):173-82. doi: 10.1023/a:1008130917204.
The Kansas/15626/84 (Ka) and Shipping Fever (SF) strains of bovine parainfluenza virus type 3 (BPIV3) replicate less efficiently than human PIV3 (HPIV3) in the upper and lower respiratory tract of rhesus monkeys, and BPIV3 Ka is also highly attenuated in humans and is in clinical trials as a candidate vaccine against HPIV3. To initiate an investigation of the genetic basis of the observed attenuation phenotype of BPIV3 in primates, the complete genomic sequences of Ka and SF genomes were determined and compared to those of BPIV3 strain 910N and two HPIV3 strains, JS and Wash/47885/57. There is a high degree of identity between the five PIV3 viruses in their 55 nucleotide (nt) leader (83.6%) and 44 nt trailer (93.2%) sequences. The five viruses display amino acid sequence identity ranging from 58.6% for the phosphoprotein to 89.7% for the matrix protein. Interestingly, the majority of amino acid residues found to be variable at a given position in a five-way protein alignment are nonetheless identical within the viruses of either host species (BPIV3 or HPIV3). These host-specific residues might be products of distinct selective pressures on BPIV3 and HPIV3 during evolution in their respective hosts. These host-specific sequences likely include ones which are responsible for the host range differences, such as the efficient growth of BPIV3 in bovines compared to its restricted growth in primates. It should now be possible using the techniques of reverse genetics to import sequences from BPIV3 into HPIV3 and identify those nt or protein sequences which attenuate HPIV3 for primates. This information should be useful in understanding virus-host interactions and in the development of vaccines to protect against HPIV3-induced disease.
牛副流感病毒3型(BPIV3)的堪萨斯/15626/84(Ka)株和运输热(SF)株在恒河猴的上、下呼吸道中的复制效率低于人副流感病毒3型(HPIV3),并且BPIV3 Ka株在人体中也高度减毒,目前正作为抗HPIV3候选疫苗进行临床试验。为了开始研究BPIV3在灵长类动物中观察到的减毒表型的遗传基础,测定了Ka株和SF株基因组的完整序列,并将其与BPIV3 910N株以及两株HPIV3毒株JS和Wash/47885/57的序列进行比较。这五种PIV3病毒在其55个核苷酸(nt)的前导序列(83.6%)和44 nt的尾序列(93.2%)上具有高度同一性。这五种病毒的氨基酸序列同一性范围从磷蛋白的58.6%到基质蛋白的89.7%。有趣的是,在五重蛋白质比对中给定位置发现的大多数可变氨基酸残基在任一宿主物种(BPIV3或HPIV3)的病毒中仍然是相同的。这些宿主特异性残基可能是BPIV3和HPIV3在各自宿主进化过程中受到不同选择压力的产物。这些宿主特异性序列可能包括那些导致宿主范围差异的序列,例如BPIV3在牛中高效生长而在灵长类动物中生长受限。现在应该可以利用反向遗传学技术将BPIV3的序列导入HPIV3,并鉴定出那些使HPIV3对灵长类动物减毒的nt或蛋白质序列。这些信息对于理解病毒-宿主相互作用以及开发预防HPIV3诱导疾病的疫苗应该是有用的。